INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPTPRNewsWire • Thursday
EyePoint Reports Third Quarter 2026 Financial Results and Provides Recent Corporate DevelopmentsGlobeNewsWire • Thursday
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific MeetingsGlobeNewsWire • 11/06/26
EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/28/26
EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & KorsinskyGlobeNewsWire • 10/26/26
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving EyePoint Pharmaceuticals (EYPT)GlobeNewsWire • 10/22/26
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint PharmaceuticalsPRNewsWire • 10/20/26
EyePoint Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into EyePoint Pharmaceuticals (EYPT)PRNewsWire • 10/19/26
EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration Prepared Remarks TranscriptSeeking Alpha • 10/19/26
This Biotech Stock Sinks Below $1 After Key Eye Drug Fails and Staff Is Slashed. Why There's Still Hope.Barrons • 10/19/26
EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMDGlobeNewsWire • 10/19/26
These beaten-down stocks could bounce back in January, if history is any guideMarket Watch • 09/21/26
EyePoint, Inc. (EYPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
EYPT Investigation Alert: EyePoint, Inc. Investors Encouraged to Contact Kessler Topaz Meltzer & Check, LLPGlobeNewsWire • 09/10/26
EyePoint, Inc. (EYPT) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/09/26
Investigation Alert: EyePoint, Inc. (EYPT) Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLPPRNewsWire • 09/06/26
EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law FirmGlobeNewsWire • 09/04/26
EYPT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving EyePoint PharmaceuticalsGlobeNewsWire • 09/03/26